you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

BSE Live

Nov 27, 16:00
471.20 2.45 (0.52%)
Volume
AVERAGE VOLUME
5-Day
126,938
10-Day
102,186
30-Day
110,622
83,915
  • Prev. Close

    468.75

  • Open Price

    471.00

  • Bid Price (Qty.)

    471.20 (364)

  • Offer Price (Qty.)

    475.00 (20)

NSE Live

Nov 27, 15:59
471.40 2.50 (0.53%)
Volume
AVERAGE VOLUME
5-Day
2,331,184
10-Day
1,791,223
30-Day
2,604,252
2,060,073
  • Prev. Close

    468.90

  • Open Price

    471.00

  • Bid Price (Qty.)

    471.40 (9292)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2019 2018 2017 2016 2015
Yearly Results of Glenmark Pharma (in Rs. Cr.) Mar '20 Mar '19 Mar '18 Mar '17 Mar '16  
Net Sales/Income from operations 6,491.20 6,131.14 6,096.05 7,694.83 5,906.97  
Other Operating Income 221.43 173.73 335.83 400.67 296.11  
Total Income From Operations 6,712.63 6,304.87 6,431.88 8,095.50 6,203.08  
EXPENDITURE  
Consumption of Raw Materials 2,251.98 1,585.85 2,038.57 2,242.01 1,792.24  
Purchase of Traded Goods 365.24 301.30 288.18 267.00 219.98  
Increase/Decrease in Stocks 48.77 471.81 51.85 -83.52 -73.55  
Power & Fuel -- -- -- -- --  
Employees Cost 1,072.33 969.98 1,021.92 914.47 766.25  
Depreciation 138.54 106.28 118.20 104.93 99.81  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 1,670.08 1,648.45 1,683.87 1,856.90 1,732.98  
P/L Before Other Inc. , Int., Excpt. Items & Tax 1,165.69 1,221.20 1,229.30 2,793.71 1,665.37  
Other Income 606.79 475.61 180.42 148.24 117.38  
P/L Before Int., Excpt. Items & Tax 1,772.48 1,696.81 1,409.72 2,941.95 1,782.75  
Interest 256.39 223.81 190.90 152.60 36.22  
P/L Before Exceptional Items & Tax 1,516.09 1,473.00 1,218.83 2,789.35 1,746.53  
Exceptional Items 18.55 345.19 -- -236.45 --  
P/L Before Tax 1,534.64 1,818.18 1,218.83 2,552.90 1,746.53  
Tax 180.10 329.88 204.48 412.29 262.26  
P/L After Tax from Ordinary Activities 1,354.55 1,488.30 1,014.35 2,140.61 1,484.27  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- 133.81 -- -- --  
Net Profit/(Loss) For the Period 1,354.55 1,622.11 1,014.35 2,140.61 1,484.27  
Equity Share Capital 28.22 28.22 28.22 28.22 28.22  
Reserves Excluding Revaluation Reserves 13,198.05 11,913.87 10,363.22 9,408.40 7,337.75  
Equity Dividend Rate (%) 250.00 200.00 200.00 200.00 200.00  
EPS Before Extra Ordinary  
Basic EPS 48.00 52.75 35.95 75.86 52.94  
Diluted EPS 48.00 52.74 35.94 75.84 52.93  
EPS After Extra Ordinary  
Basic EPS. 48.00 52.75 35.95 75.86 52.94  
Diluted EPS. 48.00 52.74 35.94 75.84 52.93  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited